Cost-effectiveness of novel algorithms for rapid diagnosis of tuberculosis in HIV-infected individuals in Uganda.
作者： Willy Ssengooba , Yukari C. Manabe , Jerrold Ellner , Susan E. Dorman , Maunank Shah
DOI: 10.1097/QAD.0000000000000008
关键词: Hiv infected 、 Immunology 、 Lipoarabinomannan 、 Human immunodeficiency virus (HIV) 、 Active tb 、 Tuberculosis 、 Sputum 、 Virology 、 Medicine 、 Diagnostic algorithms 、 Cost effectiveness
摘要: Objective Xpert MTB/RIF (‘Xpert’) and urinary lateral-flow lipoarabinomannan (LF-LAM) assays offer rapid tuberculosis (TB) diagnosis. This study evaluated the cost-effectiveness of novel diagnostic algorithms utilizing combinations Xpert LF-LAM for detection active TB among people living with HIV.
elsevier.com
researchgate.net 
sci-hub.se 参考文章(33)
C. Lienhardt, K. Manneh, K. P. W. J. Mcadam, P. Milligan, D. Needham, J. Rowley, G. Lahai, Factors affecting time delay to treatment in a tuberculosis control programme in a sub-Saharan African country: the experience of The Gambia. International Journal of Tuberculosis and Lung Disease. ,vol. 5, pp. 233- 239 ,(2001)
W A Githui, M R A van Cleeff, J A Odhiambo, Paul R Klatser, D K Kibuga, L E A Kivihya-Ndugga, L W Nganga, A comprehensive comparison of Ziehl-Neelsen and fluorescence microscopy for the diagnosis of tuberculosis in a resource-poor urban setting. International Journal of Tuberculosis and Lung Disease. ,vol. 7, pp. 1163- 1171 ,(2003)
Kai Chang, Weiping Lu, Junji Wang, Kejun Zhang, Shuangrong Jia, Fake Li, Shaoli Deng, Ming Chen, Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: A meta-analysis Journal of Infection. ,vol. 64, pp. 580- 588 ,(2012) , 10.1016/J.JINF.2012.02.012
D. Sun, S. Dorman, M. Shah, Y. C. Manabe, V. M. Moodley, M. P. Nicol, D. W. Dowdy, Cost utility of lateral-flow urine lipoarabinomannan for tuberculosis diagnosis in HIV-infected African adults. International Journal of Tuberculosis and Lung Disease. ,vol. 17, pp. 552- 558 ,(2013) , 10.5588/IJTLD.12.0627
Edward J Mills, Celestin Bakanda, Josephine Birungi, Robert Mwesigwa, Keith Chan, Nathan Ford, Robert S Hogg, Curtis Cooper, Mortality by baseline CD4 cell count among HIV patients initiating antiretroviral therapy: evidence from a large cohort in Uganda. AIDS. ,vol. 25, pp. 851- 855 ,(2011) , 10.1097/QAD.0B013E32834564E9
Kwonjune J. Seung, David B. Omatayo, Salmaan Keshavjee, Jennifer J. Furin, Paul E. Farmer, Hind Satti, Early outcomes of MDR-TB treatment in a high HIV-prevalence setting in Southern Africa. PLOS ONE. ,vol. 4, ,(2009) , 10.1371/JOURNAL.PONE.0007186
Yukari C. Manabe, Sabine M. Hermans, Mohammed Lamorde, Barbara Castelnuovo, C. Daniel Mullins, Andreas Kuznik, Rifampicin for Continuation Phase Tuberculosis Treatment in Uganda: A Cost-Effectiveness Analysis PLoS ONE. ,vol. 7, pp. e39187- ,(2012) , 10.1371/JOURNAL.PONE.0039187
Nigel Field, Jill Murray, Michelle L Wong, Rob Dowdeswell, Ntomboxolo Dudumayo, Lesego Rametsi, Neil Martinson, Marc Lipman, Judith R Glynn, Pam Sonnenberg, Missed opportunities in TB diagnosis: a TB process-based performance review tool to evaluate and improve clinical care. BMC Public Health. ,vol. 11, pp. 127- 127 ,(2011) , 10.1186/1471-2458-11-127
Maunank Shah, Willy Ssengooba, Derek Armstrong, Lydia Nakiyingi, Molly Holshouser, Jerrold J. Ellner, Moses Joloba, Yukari C. Manabe, Susan E. Dorman, Comparative performance of urinary lipoarabinomannan assays and Xpert MTB/RIF in HIV-infected individuals. AIDS. ,vol. 28, pp. 1307- 1314 ,(2014) , 10.1097/QAD.0000000000000264
Richard A. Hirth, Michael E. Chernew, Edward Miller, A. Mark Fendrick, William G. Weissert, Willingness to Pay for a Quality-adjusted Life Year: In Search of a Standard Medical Decision Making. ,vol. 20, pp. 332- 342 ,(2000) , 10.1177/0272989X0002000310